Renewed Response to Pembrolizumab After Salvage Radiotherapy for Oligoprogression in Advanced NSCLC: A Case Report
{{output}}
Immune checkpoint inhibitor (ICI) rechallenge may benefit selected patients with NSCLC, but the role of local radiotherapy for oligoprogression and late same-agent rechallenge remains uncertain. We report a patient with Stage IVA lung adenocarcinoma and a prog... ...
